特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
933794

医療分析試験サービス市場:種類(分析方法開発/評価、セルベースアッセイ、安定性試験、重金属試験、画像分析、ウイルス検査)、エンドユーザー別:2025年までの世界市場予測

Healthcare Analytical Testing Services Market by Type (Method Development & Validation, Cell-Based Assays, Stability Testing, Heavy Metal Testing, Image Analysis, Virology Testing) & End user - Global Forecast to 2025

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 328 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
医療分析試験サービス市場:種類(分析方法開発/評価、セルベースアッセイ、安定性試験、重金属試験、画像分析、ウイルス検査)、エンドユーザー別:2025年までの世界市場予測
出版日: 2020年04月24日
発行: MarketsandMarkets
ページ情報: 英文 328 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

2020年に49億米ドル規模の医療分析試験サービス市場は、調査期間中に2025年までに84億米ドル規模に達し、CAGRは11.4%になる見込みとなっております。この成長は、生物学的製剤やバイオシミラーの分析検査への焦点のシフト、製薬会社による分析検査のアウトソーシングの増加、製薬研究/製造におけるQbDアプローチの受け入れの増加、研究開発アウトソーシングにおけるFTE契約の採用に起因しています。

当レポートでは、世界の医療分析試験サービス市場について調査分析を行い、市場概要、種類、エンドユーザー、地域別に市場を考察するとともに、競合状況、企業プロファイルなどについて包括的にまとめています。

933794_4.3 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET REGIONAL MIX (2020–2025)_FIGURE 13

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 考察

  • 医療分析試験サービス市場の概要
  • 医療分析試験サービス市場:地域別成長機会
  • 医療分析試験サービス市場:地域市場(2020年~2025年)
  • 医療分析試験サービス市場:先進国VS発展途上国

第5章 市場概要

  • イントロダクション
  • 市場のダイナミクス

第6章 産業の考察

  • 産業の動向
  • 規制の分析
  • 医療分析試験サービス市場へのCOVID-19の影響

第7章 医療分析試験サービス市場:種類別

  • イントロダクション
  • 生物分析試験サービス
  • 物理的特性化サービス
  • 分析法開発/評価サービス
  • 原料試験サービス
  • バッチリリース試験サービス
  • 安定性試験サービス
  • 微生物試験サービス
  • 環境モニタリングサービス

第8章 医療分析試験サービス市場:エンドユーザー別

  • イントロダクション
  • 製薬会社/バイオ医薬品企業
  • 医療機器会社
  • 医薬品開発業務受託機関

第9章 医療分析試験サービス市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東/アフリカ

第10章 競合状況

第11章 企業プロファイル

  • EUROFINS SCIENTIFIC
  • LABCORP
  • SGS
  • CHARLES RIVER LABORATORIES
  • WUXI PHARMATECH
  • PPD
  • ELEMENT MATERIALS TECHNOLOGY
  • PACE ANALYTICAL
  • INTERTEK
  • MERCK KGAA
  • SOURCE BIOSCIENCE
  • ALMAC GROUP
  • ICON
  • FRONTAGE LABS
  • STERIS PLC
  • PRA HEALTH SCIENCES
  • SYNEOS HEALTH
  • MEDPACE
  • LGC LIMITED
  • ANACURA

第12章 付録

図表

LIST OF TABLES

  • TABLE 1 PATENT EXPIRY OF BEST-SELLING BIOLOGICS 51
  • TABLE 2 ICH QUALITY GUIDELINES FOR PHARMACEUTICAL GMPS 59
  • TABLE 3 DEVELOPMENT OF GLP ACROSS COUNTRIES 60
  • TABLE 4 OVERVIEW OF GUIDELINES OF LABORATORY SERVICES 61
  • TABLE 5 REGULATORY AUTHORITIES AND LAUNCH OF GLP MONITORING PROGRAMS IN EUROPEAN COUNTRIES 61
  • TABLE 6 DRUGS UNDER TRIAL FOR THE TREATMENT OF COVID-19 63
  • TABLE 7 VACCINES CURRENTLY UNDER TRIAL FOR THE TREATMENT OF COVID-19 63
  • TABLE 8 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 65
  • TABLE 9 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 66
  • TABLE 10 BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 67
  • TABLE 11 CELL-BASED ASSAY SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 68
  • TABLE 12 VIROLOGY TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 69
  • TABLE 13 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 71
  • TABLE 14 BIOMARKER TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 72
  • TABLE 15 PHARMACOKINETIC TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 73
  • TABLE 16 OTHER BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 74
  • TABLE 17 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 75
  • TABLE 18 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 76
  • TABLE 19 LASER PARTICLE SIZE ANALYSIS SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 77
  • TABLE 20 THERMAL ANALYSIS SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 78
  • TABLE 21 IMAGE ANALYSIS SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 80
  • TABLE 22 SURFACE AREA ANALYSIS SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 81
  • TABLE 23 OTHER PHYSICAL CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 82
  • TABLE 24 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 83
  • TABLE 25 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 84
  • TABLE 26 EXTRACTABLE & LEACHABLE METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 85
  • TABLE 27 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 86
  • TABLE 28 STABILITY-INDICATING METHOD VALIDATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 87
  • TABLE 29 CLEANING VALIDATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 88
  • TABLE 30 ANALYTICAL STANDARD CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 90
  • TABLE 31 TECHNICAL CONSULTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 91
  • TABLE 32 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 92
  • TABLE 33 RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 93
  • TABLE 34 RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 93
  • TABLE 35 COMPLETE COMPENDIAL TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 94
  • TABLE 36 HEAVY METAL TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 95
  • TABLE 37 CONTAINER TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 97
  • TABLE 38 KARL FISCHER ANALYSIS TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 98
  • TABLE 39 WET CHEMISTRY ANALYSIS TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 99
  • TABLE 40 OTHER RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 100
  • TABLE 41 BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 101
  • TABLE 42 BATCH-RELEASE TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 101
  • TABLE 43 EVOLUTION OF FDA GUIDELINES FOR DISSOLUTION TESTING 102
  • TABLE 44 DISSOLUTION TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 103
  • TABLE 45 ELEMENTAL IMPURITY TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 104
  • TABLE 46 BREAKDOWN OF DISINTEGRATION METHODS AND IMMERSION MEDIA 105
  • TABLE 47 DISINTEGRATION TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 106
  • TABLE 48 HARDNESS TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 107
  • TABLE 49 FRIABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 108
  • TABLE 50 OTHER BATCH-RELEASE TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 109
  • TABLE 51 STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 110
  • TABLE 52 STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 110
  • TABLE 53 DRUG SUBSTANCE STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 111
  • TABLE 54 FORMULATION EVALUATION STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 112
  • TABLE 55 ACCELERATED STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 113
  • TABLE 56 PHOTOSTABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 115
  • TABLE 57 COMPARATIVE STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 116
  • TABLE 58 OTHER STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 117
  • TABLE 59 MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 118
  • TABLE 60 MICROBIAL TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 119
  • TABLE 61 STANDARD LIMITS FOR MICROBIAL LIMIT TESTING 120
  • TABLE 62 MICROBIAL LIMIT TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 120
  • TABLE 63 STERILITY TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 122
  • TABLE 64 ENDOTOXIN TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 123
  • TABLE 65 PRESERVATIVE EFFICACY TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 124
  • TABLE 66 STANDARDIZED LIMITS FOR WATER TESTING 125
  • TABLE 67 WATER TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 125
  • TABLE 68 OTHER MICROBIAL TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 126
  • TABLE 69 ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 127
  • TABLE 70 ENVIRONMENTAL MONITORING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 128
  • TABLE 71 PURITY CLASSES FOR PARTICLES, WATER, AND OIL IN COMPRESSED AIR 129
  • TABLE 72 AIR TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 130
  • TABLE 73 STANDARDS FOR WASTEWATER QUALITY 131
  • TABLE 74 WASTEWATER/ETP TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 131
  • TABLE 75 OTHER ENVIRONMENTAL MONITORING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 132
  • TABLE 76 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 134
  • TABLE 77 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION) 136
  • TABLE 78 R&D SPENDING OF LEADING MEDICAL DEVICES COMPANIES, 2018 (USD BILLION) 137
  • TABLE 79 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION) 138
  • TABLE 80 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR CROS, BY COUNTRY, 2018-2025 (USD MILLION) 139
  • TABLE 81 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION) 142
  • TABLE 82 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 145
  • TABLE 83 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 145
  • TABLE 84 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 146
  • TABLE 85 NORTH AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 146
  • TABLE 86 NORTH AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 147
  • TABLE 87 NORTH AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 147
  • TABLE 88 NORTH AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 148
  • TABLE 89 NORTH AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 148
  • TABLE 90 NORTH AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 149
  • TABLE 91 NORTH AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 149
  • TABLE 92 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 149
  • TABLE 93 US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 151
  • TABLE 94 US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 151
  • TABLE 95 US: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 152
  • TABLE 96 US: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 152
  • TABLE 97 US: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 153
  • TABLE 98 US: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 153
  • TABLE 99 US: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 154
  • TABLE 100 US: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 154
  • TABLE 101 US: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 155
  • TABLE 102 US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 155
  • TABLE 103 NUMBER OF ACTIVE CLINICAL TRIALS IN CANADA, BY CONDITION (2019) 156
  • TABLE 104 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 156
  • TABLE 105 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 157
  • TABLE 106 CANADA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 157
  • TABLE 107 CANADA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 158
  • TABLE 108 CANADA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 158
  • TABLE 109 CANADA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 159
  • TABLE 110 CANADA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 159
  • TABLE 111 CANADA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 160
  • TABLE 112 CANADA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 160
  • TABLE 113 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 160
  • TABLE 114 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 163
  • TABLE 115 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 163
  • TABLE 116 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 164
  • TABLE 117 EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 164
  • TABLE 118 EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 165
  • TABLE 119 EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 165
  • TABLE 120 EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 166
  • TABLE 121 EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 166
  • TABLE 122 EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 167
  • TABLE 123 EUROPE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 167
  • TABLE 124 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 167
  • TABLE 125 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 169
  • TABLE 126 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 169
  • TABLE 127 GERMANY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 170
  • TABLE 128 GERMANY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 170
  • TABLE 129 GERMANY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 171
  • TABLE 130 GERMANY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 171
  • TABLE 131 GERMANY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 172
  • TABLE 132 GERMANY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 172
  • TABLE 133 GERMANY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 173
  • TABLE 134 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 173
  • TABLE 135 UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 174
  • TABLE 136 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 175
  • TABLE 137 UK: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 175
  • TABLE 138 UK: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 176
  • TABLE 139 UK: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 176
  • TABLE 140 UK: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 177
  • TABLE 141 UK: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 177
  • TABLE 142 UK: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 178
  • TABLE 143 UK: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 178
  • TABLE 144 UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 178
  • TABLE 145 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 179
  • TABLE 146 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 180
  • TABLE 147 FRANCE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 180
  • TABLE 148 FRANCE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 181
  • TABLE 149 FRANCE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 181
  • TABLE 150 FRANCE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 182
  • TABLE 151 FRANCE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 182
  • TABLE 152 FRANCE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 183
  • TABLE 153 FRANCE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 183
  • TABLE 154 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 183
  • TABLE 155 NUMBER OF CLINICAL TRIALS STARTED IN ITALY, BY COMPANY (2017) 184
  • TABLE 156 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 185
  • TABLE 157 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 185
  • TABLE 158 ITALY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 186
  • TABLE 159 ITALY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 186
  • TABLE 160 ITALY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 187
  • TABLE 161 ITALY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 187
  • TABLE 162 ITALY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 188
  • TABLE 163 ITALY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 188
  • TABLE 164 ITALY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 189
  • TABLE 165 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 189
  • TABLE 166 SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 190
  • TABLE 167 SWITZERLAND: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 190
  • TABLE 168 SWITZERLAND: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 191
  • TABLE 169 SWITZERLAND: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 191
  • TABLE 170 SWITZERLAND: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 192
  • TABLE 171 SWITZERLAND: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 192
  • TABLE 172 SWITZERLAND: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 193
  • TABLE 173 SWITZERLAND: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 193
  • TABLE 174 SWITZERLAND: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 194
  • TABLE 175 SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 194
  • TABLE 176 SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 196
  • TABLE 177 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 196
  • TABLE 178 SPAIN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 197
  • TABLE 179 SPAIN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 197
  • TABLE 180 SPAIN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 198
  • TABLE 181 SPAIN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 198
  • TABLE 182 SPAIN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 199
  • TABLE 183 SPAIN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 199
  • TABLE 184 SPAIN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 200
  • TABLE 185 SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 200
  • TABLE 186 ROE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 201
  • TABLE 187 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 201
  • TABLE 188 ROE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 202
  • TABLE 189 ROE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 202
  • TABLE 190 ROE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 203
  • TABLE 191 ROE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 203
  • TABLE 192 ROE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 204
  • TABLE 193 ROE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 204
  • TABLE 194 ROE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 205
  • TABLE 195 ROE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 205
  • TABLE 196 APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 207
  • TABLE 197 APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 207
  • TABLE 198 APAC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 208
  • TABLE 199 APAC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 208
  • TABLE 200 APAC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 209
  • TABLE 201 APAC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 209
  • TABLE 202 APAC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 210
  • TABLE 203 APAC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 210
  • TABLE 204 APAC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 211
  • TABLE 205 APAC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 211
  • TABLE 206 APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 211
  • TABLE 207 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 212
  • TABLE 208 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 213
  • TABLE 209 CHINA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 213
  • TABLE 210 CHINA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 214
  • TABLE 211 CHINA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 214
  • TABLE 212 CHINA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 215
  • TABLE 213 CHINA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 215
  • TABLE 214 CHINA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 216
  • TABLE 215 CHINA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 216
  • TABLE 216 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 217
  • TABLE 217 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 218
  • TABLE 218 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 218
  • TABLE 219 JAPAN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 219
  • TABLE 220 JAPAN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 219
  • TABLE 221 JAPAN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 220
  • TABLE 222 JAPAN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 220
  • TABLE 223 JAPAN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 221
  • TABLE 224 JAPAN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 221
  • TABLE 225 JAPAN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 222
  • TABLE 226 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 222
  • TABLE 227 INCREASE IN R&D EXPENDITURE OF TOP FIVE INDIAN PHARMACEUTICAL COMPANIES, 2010 VS. 2018 (USD MILLION) 223
  • TABLE 228 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 223
  • TABLE 229 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 224
  • TABLE 230 INDIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 224
  • TABLE 231 INDIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 225
  • TABLE 232 INDIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 225
  • TABLE 233 INDIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 226
  • TABLE 234 INDIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 226
  • TABLE 235 INDIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 227
  • TABLE 236 INDIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 227
  • TABLE 237 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 227
  • TABLE 238 AUSTRALIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 228
  • TABLE 239 AUSTRALIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 229
  • TABLE 240 AUSTRALIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 229
  • TABLE 241 AUSTRALIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 230
  • TABLE 242 AUSTRALIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 230
  • TABLE 243 AUSTRALIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 231
  • TABLE 244 AUSTRALIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 231
  • TABLE 245 AUSTRALIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 232
  • TABLE 246 AUSTRALIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 232
  • TABLE 247 AUSTRALIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 233
  • TABLE 248 SOUTH KOREA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 234
  • TABLE 249 SOUTH KOREA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 234
  • TABLE 250 SOUTH KOREA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 235
  • TABLE 251 SOUTH KOREA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 235
  • TABLE 252 SOUTH KOREA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 236
  • TABLE 253 SOUTH KOREA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 236
  • TABLE 254 SOUTH KOREA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 237
  • TABLE 255 SOUTH KOREA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 237
  • TABLE 256 SOUTH KOREA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 238
  • TABLE 257 SOUTH KOREA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 238
  • TABLE 258 ROAPAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 239
  • TABLE 259 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 239
  • TABLE 260 ROAPAC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 240
  • TABLE 261 ROAPAC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 240
  • TABLE 262 ROAPAC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 241
  • TABLE 263 ROAPAC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 241
  • TABLE 264 ROAPAC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 242
  • TABLE 265 ROAPAC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 242
  • TABLE 266 ROAPAC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 243
  • TABLE 267 ROAPAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 243
  • TABLE 268 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 244
  • TABLE 269 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 245
  • TABLE 270 LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 245
  • TABLE 271 LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 246
  • TABLE 272 LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 246
  • TABLE 273 LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 247
  • TABLE 274 LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 247
  • TABLE 275 LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 248
  • TABLE 276 LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 248
  • TABLE 277 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 248
  • TABLE 278 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 249
  • TABLE 279 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 250
  • TABLE 280 MIDDLE EAST & AFRICA: PHYSICAL CHARACTERIZATION MARKET, BY TYPE, 2018-2025 (USD MILLION) 250
  • TABLE 281 MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 251
  • TABLE 282 MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 251
  • TABLE 283 MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 252
  • TABLE 284 MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 252
  • TABLE 285 MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 253
  • TABLE 286 MIDDLE EAST & AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 253
  • TABLE 287 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION) 253
  • TABLE 288 SERVICE LAUNCHES AND UPGRADES, 2017-2020 260
  • TABLE 289 ACQUISITIONS, 2017-2020 260
  • TABLE 290 PARTNERSHIPS, 2017-2020 261
  • TABLE 291 EXPANSIONS, 2017-2020 261

LIST OF FIGURES

  • FIGURE 1 RESEARCH DESIGN 33
  • FIGURE 2 PRIMARY SOURCES 35
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 36
  • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
  • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
  • FIGURE 6 DATA TRIANGULATION METHODOLOGY 40
  • FIGURE 7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 42
  • FIGURE 8 BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020 VS. 2025 43
  • FIGURE 9 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 44
  • FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 45
  • FIGURE 11 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET IS PROJECTED TO WITNESS DOUBLE-DIGIT GROWTH RATE 46
  • FIGURE 12 CHINA TO REGISTER THE HIGHEST GROWTH IN THE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET DURING THE FORECAST PERIOD 47
  • FIGURE 13 APAC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2019-2025) 48
  • FIGURE 14 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD 49
  • FIGURE 15 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
  • FIGURE 16 INCREASING NUMBER OF CLINICAL TRIALS WORLDWIDE (2002-2020) 53
  • FIGURE 17 EMPHASIS ON INORGANIC GROWTH AND PREFERENCE FOR LONG-TERM COLLABORATIONS OVER SHORT-TERM CONTRACTS ARE KEY MARKET TRENDS 57
  • FIGURE 18 MARKET DEVELOPMENTS, BY TYPE, 2017-2020: ACQUISITIONS FORM THE MOST-ADOPTED STRATEGY 58
  • FIGURE 19 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES SEGMENT TO DOMINATE THE MARKET IN 2025 134
  • FIGURE 20 R&D SPENDING OF PHRMA MEMBER-COMPANIES, 1995-2018 135
  • FIGURE 21 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 141
  • FIGURE 22 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (2019) 143
  • FIGURE 23 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SNAPSHOT 144
  • FIGURE 24 US: PIPELINE SPLIT OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY PHASE (JANUARY 2019) 150
  • FIGURE 25 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SNAPSHOT 162
  • FIGURE 26 SPAIN: PHARMACEUTICAL R&D EXPENDITURE, 2011-2017 195
  • FIGURE 27 APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SNAPSHOT 206
  • FIGURE 28 ACQUISITIONS-THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS 255
  • FIGURE 29 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2019 257
  • FIGURE 30 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019) 259
  • FIGURE 31 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019) 262
  • FIGURE 32 LABCORP: COMPANY SNAPSHOT (2019) 268
  • FIGURE 33 SGS: COMPANY SNAPSHOT (2019) 273
  • FIGURE 34 CHARLES RIVER LABORATORY: COMPANY SNAPSHOT (2019) 277
  • FIGURE 35 WUXI PHARMATECH: COMPANY SNAPSHOT (2019) 281
  • FIGURE 36 INTERTEK: COMPANY SNAPSHOT (2019) 293
  • FIGURE 37 MERCK: COMPANY SNAPSHOT (2019) 297
  • FIGURE 38 ICON PLC: COMPANY SNAPSHOT (2019) 303
  • FIGURE 39 FRONTAGE LABS: COMPANY SNAPSHOT (2018) 306
  • FIGURE 40 STERIS PLC: COMPANY SNAPSHOT (2019) 309
目次
Product Code: AST 4341

"The healthcare analytical testing services market is projected to grow at a CAGR of 11.4%."

The global healthcare analytical testing services market size is projected to reach USD 8.4 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 11.4% during the forecast period. Market growth is attributed to the shift of focus towards the analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, increasing acceptance of the QbD approach in pharma research/manufacturing, and the adoption of FTE contracts in R&D outsourcing.

"By type, within the bioanalytical testing services segment, cell-based assay services hold the largest share in the forecast period."

Based on type, the healthcare analytical testing services market has been segmented into bioanalytical testing services, physical characterization services, method development & validation services, raw material testing services, and batch-release testing services, among others. Bioanalytical testing services accounted for the largest share of the market in 2019. Within this segment, the cell-based assay services segment is expected to grow at the highest CAGR. This is due to their ability to provide relevant in vivo biological information in comparison to biochemical assays.

"By end user, the medical device companies segment is expected to grow at the fastest rate during the forecast period (2020-2025)"

Based on End User, the healthcare analytical testing services market has been segmented into pharmaceutical & biopharmaceutical companies, medical device companies, and CROs. The medical device companies segment is expected to grow at the highest CAGR due to increasing demand by OEMs for more services and expertise, an evolving regulatory scenario, technological advancements in medical devices, and the adoption of POC testing.

"North America to hold the largest share."

North America is expected to account for the largest share of the global healthcare analytical testing services market in 2019. The large share of this region can primarily be attributed to the presence of a well-established base of pharmaceutical and biopharmaceutical companies, high investments in the biosimilars and biologics segment, and increasing R&D expenditure. On the other hand, the APAC is expected to witness the highest CAGR during the forecast period due to the large number of qualified researchers, low cost of operations in APAC countries, presence of a large treatment-naive population, retention of participants in clinical trials, and continuously improving regulatory procedures.

The breakdown of primary participants is mentioned below:

  • By Company Type: Tier 1-30%, Tier 2-45%, and Tier 3-25%
  • By Designation: C-level-35%, Director Level-25%, and Others-40%
  • By Region: North America-35%, Europe-30%, the Asia Pacific-15%, Latin America-10%, Middle East & Africa - 10%

Research Coverage:

The report analyzes the various healthcare analytical testing services products and their adoption patterns in different industries such as pharmaceutical and biopharmaceutical companies, medical device companies, and CROs. It aims at estimating the market size and future growth potential of the global healthcare analytical testing services market for different segments such as by type, end user, and regions. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the service portfolios offered by the top players in the global healthcare analytical testing services market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global healthcare analytical testing services market
  • Market Development: Comprehensive information on lucrative emerging regions, by type and end user.
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global healthcare analytical testing services market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and services offered by leading players in the global healthcare analytical testing services market

TABLE OF CONTENTS

1 INTRODUCTION 29

  • 1.1 OBJECTIVES OF THE STUDY 29
  • 1.2 MARKET DEFINITION 29
  • 1.3 MARKET SCOPE 30
    • 1.3.1 MARKETS COVERED 30
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY 31
  • 1.4 CURRENCY 31
  • 1.5 LIMITATIONS 31
  • 1.6 STAKEHOLDERS 32

2 RESEARCH METHODOLOGY 33

  • 2.1 RESEARCH DATA 33
    • 2.1.1 SECONDARY DATA 34
      • 2.1.1.1 Key data from secondary sources 34
    • 2.1.2 PRIMARY DATA 34
      • 2.1.2.1 Key data from primary sources 36
      • 2.1.2.2 Breakdown of primary sources 36
  • 2.2 MARKET SIZE ESTIMATION 37
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 40
  • 2.4 MARKET SHARE ESTIMATION 41
  • 2.5 ASSUMPTIONS FOR THE STUDY 41

3 EXECUTIVE SUMMARY 42

4 PREMIUM INSIGHTS 46

  • 4.1 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET OVERVIEW 46
  • 4.2 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47
  • 4.3 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: REGIONAL MIX (2020-2025) 48
  • 4.4 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 49

5 MARKET OVERVIEW 50

  • 5.1 INTRODUCTION 50
  • 5.2 MARKET DYNAMICS 51
    • 5.2.1 DRIVERS 51
      • 5.2.1.1 Focus on analytical testing of biologics & biosimilars 51
      • 5.2.1.2 Increasing outsourcing of analytical testing by pharmaceutical companies 52
      • 5.2.1.3 Increasing number of clinical trials 52
      • 5.2.1.4 Rising acceptance of the Quality-by-Design approach in pharma research and manufacturing 53
    • 5.2.2 RESTRAINTS 54
      • 5.2.2.1 Shortage of skilled professionals 54
    • 5.2.3 OPPORTUNITIES 54
      • 5.2.3.1 Specialized testing 54
      • 5.2.3.2 Emerging markets 55
    • 5.2.4 CHALLENGES 55
      • 5.2.4.1 Specific requirements of innovative formulations and medical devices 55
      • 5.2.4.2 Need to improve the sensitivity of bioanalytical methods 55

6 INDUSTRY INSIGHTS 57

  • 6.1 INDUSTRY TRENDS 57
    • 6.1.1 FOCUS ON ACQUISITIONS TO ENHANCE CAPABILITIES AND SERVICE PORTFOLIO 57
    • 6.1.2 LONG-TERM OUTSOURCING AND PREFERRED VENDOR PARTNERSHIPS 58
  • 6.2 REGULATORY ANALYSIS 58
  • 6.3 IMPACT OF COVID-19 ON HEALTHCARE ANALYTICAL TESTING SERVICES 62

7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE 64

  • 7.1 INTRODUCTION 65
  • 7.2 BIOANALYTICAL TESTING SERVICES 66
    • 7.2.1 CELL-BASED ASSAYS 67
      • 7.2.1.1 Cell-based assays help check the strength and stability of the product through all phases of clinical study 67
    • 7.2.2 VIROLOGY TESTING 69
      • 7.2.2.1 Potential effects of viral contamination support demand for testing services 69
    • 7.2.3 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING 70
      • 7.2.3.1 Increasing application of immunogenicity & neutralizing antibodies to drive the market during forecast period 70
    • 7.2.4 BIOMARKER TESTING 71
      • 7.2.4.1 Emphasis on development of personalized medicines to drive biomarker testing services market 71
    • 7.2.5 PHARMACOKINETIC TESTING 72
      • 7.2.5.1 Increasing incidence of infectious diseases will augment market growth 72
    • 7.2.6 OTHER BIOANALYTICAL TESTING SERVICES 74
  • 7.3 PHYSICAL CHARACTERIZATION SERVICES 75
    • 7.3.1 LASER PARTICLE SIZE ANALYSIS 76
      • 7.3.1.1 Need to maintain particle size uniformity and consistency in pharmaceutical drug products is driving market growth 76
    • 7.3.2 THERMAL ANALYSIS 78
      • 7.3.2.1 Rising use of analyzers in research to further support the growth of the market 78
    • 7.3.3 IMAGE ANALYSIS 79
      • 7.3.3.1 Need to identify product structures during drug development has sustained demand for image analysis 79
    • 7.3.4 SURFACE AREA ANALYSIS 80
      • 7.3.4.1 Surface area analysis helps determine performance characteristics of products 80
    • 7.3.5 OTHER PHYSICAL CHARACTERIZATION SERVICES 82
  • 7.4 METHOD DEVELOPMENT & VALIDATION SERVICES 83
    • 7.4.1 EXTRACTABLE & LEACHABLE METHOD DEVELOPMENT & VALIDATION 84
      • 7.4.1.1 Extractable studies are required to facilitate the analysis of leachables and control leachables in final drug products 84
    • 7.4.2 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION 86
      • 7.4.2.1 Presence of drug-substance and drug-product impurities to further support market growth 86
    • 7.4.3 STABILITY-INDICATING METHOD VALIDATION 87
      • 7.4.3.1 Stability testing is regarded as being essential in understanding drug quality changes over time 87
    • 7.4.4 CLEANING VALIDATION 88
      • 7.4.4.1 Cleaning validation processes are necessary to evaluate cleaning practices and ensure complete decontamination 88
    • 7.4.5 ANALYTICAL STANDARD CHARACTERIZATION 89
      • 7.4.5.1 Analytical standard characterization plays a vital role in drug development 89
    • 7.4.6 TECHNICAL CONSULTING 90
      • 7.4.6.1 Technical consulting services assist pharmaceutical and biopharmaceutical companies in meeting regulatory requirements 90
    • 7.4.7 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES 91
  • 7.5 RAW MATERIAL TESTING SERVICES 92
    • 7.5.1 COMPLETE COMPENDIAL TESTING 94
      • 7.5.1.1 Complete compendial testing detects the efficacy and safety of therapeutic products 94
    • 7.5.2 HEAVY METAL TESTING 95
      • 7.5.2.1 Heavy metals in finished pharmaceutical products and raw materials are tested to ensure the quality of the product & patient safety 95
    • 7.5.3 CONTAINER TESTING 96
      • 7.5.3.1 Container closure integrity testing helps optimize sealing, evaluate temperature impact, and replace sterility tests for product stability batches 96
    • 7.5.4 KARL FISCHER ANALYSIS 97
      • 7.5.4.1 Need to check for water content in pharmaceutical products to support the market growth 97
    • 7.5.5 WET CHEMISTRY ANALYSIS 98
      • 7.5.5.1 Wet chemistry analysis provides qualitative and quantitative data on elements in samples 98
    • 7.5.6 OTHER RAW MATERIAL TESTING SERVICES 99
  • 7.6 BATCH-RELEASE TESTING SERVICES 100
    • 7.6.1 DISSOLUTION TESTING 102
      • 7.6.1.1 Dissolution testing plays a vital role in the pharmaceutical industry, from R&D to the control and evaluation of drug quality 102
    • 7.6.2 ELEMENTAL IMPURITY TESTING 103
      • 7.6.2.1 The need to detect organic and inorganic impurities in active pharmaceuticals and ingredients drives demand for elemental impurity testing 103
    • 7.6.3 DISINTEGRATION TESTING 105
      • 7.6.3.1 Disintegration testing is performed to ensure batch-to-batch consistency of pharmaceutical dosage forms 105
    • 7.6.4 HARDNESS TESTING 106
      • 7.6.4.1 Hardness testing helps determine resistance to mechanical shocks and tablet strength 106
    • 7.6.5 FRIABILITY TESTING 107
      • 7.6.5.1 Friability testing measures the resistance of tablets and granules to abrasion or fracture 107
    • 7.6.6 OTHER BATCH-RELEASE TESTING SERVICES 108
  • 7.7 STABILITY TESTING SERVICES 109
    • 7.7.1 DRUG SUBSTANCE STABILITY TESTING 111
      • 7.7.1.1 Substance stability testing is a necessary step in the drug approval process 111
    • 7.7.2 FORMULATION EVALUATION STABILITY TESTING 112
      • 7.7.2.1 These tests provide data on expiry and storage conditions required 112
    • 7.7.3 ACCELERATED STABILITY TESTING 113
      • 7.7.3.1 Accelerated stability testing determines the shelf-life of a pharmaceutical product by measuring degradation caused by stress 113
    • 7.7.4 PHOTOSTABILITY TESTING 114
      • 7.7.4.1 Photostability tests establish the effect of light exposure on products 114
    • 7.7.5 COMPARATIVE STABILITY TESTING 115
      • 7.7.5.1 Comparator studies and blind comparator stability testing are performed to check if a pharmaceutical product is equivalent or superior to the marketed drug product in the same therapeutic class 115
    • 7.7.6 OTHER STABILITY TESTING SERVICES 116
  • 7.8 MICROBIAL TESTING SERVICES 118
    • 7.8.1 MICROBIAL LIMIT TESTING 119
      • 7.8.1.1 Microbial limit testing determines whether a product complies with compendial specifications for microbial quality 119
    • 7.8.2 STERILITY TESTING 121
      • 7.8.2.1 Sterility testing of a pharmaceutical product is required during the sterilization validation process and routine release testing to enhance product quality 121
    • 7.8.3 ENDOTOXIN TESTING 122
      • 7.8.3.1 LAL tests are used to test for the presence of endotoxins, in compliance with regulatory requirements 122
    • 7.8.4 PRESERVATIVE EFFICACY TESTING 123
      • 7.8.4.1 Preservative efficacy testing determines the type and minimum effective concentration of preservatives required for a formulation 123
    • 7.8.5 WATER TESTING 124
      • 7.8.5.1 Need to ensure water quality creates demand for water testing 124
    • 7.8.6 OTHER MICROBIAL TESTING SERVICES 126
  • 7.9 ENVIRONMENTAL MONITORING SERVICES 127
    • 7.9.1 AIR TESTING 128
      • 7.9.1.1 Air contamination can prove highly harmful to product quality, which necessitates regular testing 128
    • 7.9.2 WASTEWATER/ETP TESTING 130
      • 7.9.2.1 Need to minimize water contamination supports the demand for wastewater testing 130
    • 7.9.3 OTHER ENVIRONMENTAL MONITORING SERVICES 132

8 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER 133

  • 8.1 INTRODUCTION 134
  • 8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 135
    • 8.2.1 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DOMINATE THE HEALTHCARE TESTING SERVICES MARKET 135
  • 8.3 MEDICAL DEVICE COMPANIES 137
    • 8.3.1 R&D SPENDING ON MEDICAL DEVICE DEVELOPMENT HAS INCREASED IN RECENT YEARS 137
  • 8.4 CONTRACT RESEARCH ORGANIZATIONS 139
    • 8.4.1 INCREASING FOCUS ON OUTSOURCING WILL SUPPORT MARKET GROWTH 139

9 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION 140

  • 9.1 INTRODUCTION 141
  • 9.2 NORTH AMERICA 142
    • 9.2.1 US 150
      • 9.2.1.1 The US dominated the North American healthcare analytical testing services market in 2019 150
    • 9.2.2 CANADA 155
      • 9.2.2.1 Increasing number of clinical trials to support the growth of the market 155
  • 9.3 EUROPE 161
    • 9.3.1 GERMANY 168
      • 9.3.1.1 Germany is the largest market for healthcare analytical testing services in Europe 168
    • 9.3.2 UK 173
      • 9.3.2.1 Increasing partnerships between the government, the NHS, and the life sciences to support the market growth 173
    • 9.3.3 FRANCE 179
      • 9.3.3.1 Growing number of biologics to drive the demand for analytical testing services 179
    • 9.3.4 ITALY 184
      • 9.3.4.1 Growing number of clinical trials to support the market in Italy 184
    • 9.3.5 SWITZERLAND 189
      • 9.3.5.1 Large and growing pharma production volume will drive demand for analytical testing services 189
    • 9.3.6 SPAIN 194
      • 9.3.6.1 Rising R&D expenditure to boost the growth of analytical testing services 194
    • 9.3.7 REST OF EUROPE 200
  • 9.4 ASIA PACIFIC 205
    • 9.4.1 CHINA 212
      • 9.4.1.1 Large pharmaceutical R&D footprint in China will drive market growth 212
    • 9.4.2 JAPAN 217
      • 9.4.2.1 Japan is notable for demonstrating strong support for R&D 217
    • 9.4.3 INDIA 222
      • 9.4.3.1 India to offer lucrative growth opportunities for market players 222
    • 9.4.4 AUSTRALIA 228
      • 9.4.4.1 Australia is a favorable location for drug discovery due to the large number of research institutes in the country 228
    • 9.4.5 SOUTH KOREA 233
      • 9.4.5.1 Growth in clinical trial activity to support the market in South Korea 233
    • 9.4.6 REST OF ASIA PACIFIC 238
  • 9.5 LATIN AMERICA 243
    • 9.5.1 GROWING R&D EXPENDITURE TO DRIVE MARKET GROWTH 243
  • 9.6 MIDDLE EAST & AFRICA 249
    • 9.6.1 MIDDLE EASTERN COUNTRIES ARE BECOMING ATTRACTIVE DESTINATIONS FOR PHARMA & MEDICAL DEVICE MANUFACTURERS 249

10 COMPETITIVE LANDSCAPE 254

  • 10.1 OVERVIEW 254
  • 10.2 GROWTH STRATEGY MATRIX (2017-2020) 256
  • 10.3 MARKET SHARE ANALYSIS 257
    • 10.3.1 MARKET SHARE ANALYSIS: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 257
  • 10.4 COMPETITIVE LEADERSHIP MAPPING 258
    • 10.4.1 VISIONARY LEADERS 258
    • 10.4.2 INNOVATORS 258
    • 10.4.3 DYNAMIC DIFFERENTIATORS 258
    • 10.4.4 EMERGING COMPANIES 259
  • 10.5 COMPETITIVE SITUATION AND TRENDS 260
    • 10.5.1 SERVICE LAUNCHES AND UPGRADES 260
    • 10.5.2 ACQUISITIONS 260
    • 10.5.3 PARTNERSHIPS AND COLLABORATIONS 261
    • 10.5.4 EXPANSIONS 261

11 COMPANY PROFILES 262

(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

  • 11.1 EUROFINS SCIENTIFIC 262
  • 11.2 LABCORP 268
  • 11.3 SGS 273
  • 11.4 CHARLES RIVER LABORATORIES 277
  • 11.5 WUXI PHARMATECH 281
  • 11.6 PPD 285
  • 11.7 ELEMENT MATERIALS TECHNOLOGY 288
  • 11.8 PACE ANALYTICAL 290
  • 11.9 INTERTEK 293
  • 11.10 MERCK KGAA 297
  • 11.11 SOURCE BIOSCIENCE 299
  • 11.12 ALMAC GROUP 300
  • 11.13 ICON 303
  • 11.14 FRONTAGE LABS 306
  • 11.15 STERIS PLC 309
  • 11.16 PRA HEALTH SCIENCES 311
  • 11.17 SYNEOS HEALTH 311
  • 11.18 MEDPACE 312
  • 11.19 LGC LIMITED 313
  • 11.20 ANACURA 314

Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12 APPENDIX 315

  • 12.1 INSIGHTS OF INDUSTRY EXPERTS 315
  • 12.2 DISCUSSION GUIDE 316
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 324
  • 12.4 AVAILABLE CUSTOMIZATIONS 326
  • 12.5 RELATED REPORTS 326
  • 12.6 AUTHOR DETAILS 327
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.